EMERGENT BIOSOLUTIONS INC. Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent
EMERGENT BIOSOLUTIONS INC. (EBS) reported Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent of $100.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent · last filed 2026-08-06
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-06-30 was $100.00K.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2026-03-31 was $600.00K.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for the quarter ending 2025-09-30 was $600.00K.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2025 was -$2.30M, a 560.00% decline from fiscal 2024.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2024 was $500.00K.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2023 was -$8.80M, a 145.83% decline from fiscal 2022.
- EMERGENT BIOSOLUTIONS INC. other comprehensive income (loss), net of tax, portion attributable to parent for fiscal 2022 was $19.20M, a 108.70% increase from fiscal 2021.
| Period end | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month | Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $100.00K 10-Q · filed 2026-08-06 | $700.00K 10-Q · filed 2026-08-06 | $700.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.30M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-31 | $600.00K 10-Q · filed 2026-08-06 | $600.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.20M derived: sum of 3 quarters · filed 2026-08-06 | -$800.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $600.00K derived: sum of 2 quarters · filed 2026-02-27 | -$1.40M derived: sum of 3 quarters · filed 2026-08-06 | -$2.30M 10-K · filed 2026-02-27 | |
| 2025-09-30 | $600.00K 10-Q · filed 2025-10-30 | -$1.40M derived: sum of 2 quarters · filed 2026-08-06 | -$2.30M 10-Q · filed 2025-10-30 | -$200.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-06-30 | -$2.00M 10-Q · filed 2026-08-06 | -$2.90M 10-Q · filed 2026-08-06 | -$800.00K derived: sum of 3 quarters · filed 2026-08-06 | -$2.60M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2025-03-31 | -$900.00K 10-Q · filed 2026-08-06 | $1.20M derived: sum of 2 quarters · filed 2026-08-06 | -$600.00K derived: sum of 3 quarters · filed 2026-08-06 | -$600.00K derived: sum of 4 quarters · filed 2026-08-06 | |
| 2024-12-31 | $2.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $300.00K derived: sum of 2 quarters · filed 2026-02-27 | $300.00K derived: sum of 3 quarters · filed 2026-02-27 | $500.00K 10-K · filed 2026-02-27 | |
| 2024-09-30 | -$1.80M 10-Q · filed 2025-10-30 | -$1.80M derived: sum of 2 quarters · filed 2025-10-30 | -$1.60M 10-Q · filed 2025-10-30 | -$4.70M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $200.00K 10-Q · filed 2025-08-07 | -$2.90M derived: sum of 3 quarters · filed 2026-02-27 | -$3.90M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2024-03-31 | $200.00K 10-Q · filed 2025-10-30 | -$2.90M derived: sum of 2 quarters · filed 2026-02-27 | -$3.90M derived: sum of 3 quarters · filed 2026-02-27 | -$6.50M derived: sum of 4 quarters · filed 2026-02-27 | |
| 2023-12-31 | -$3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$4.10M derived: sum of 2 quarters · filed 2026-02-27 | -$6.70M derived: sum of 3 quarters · filed 2026-02-27 | -$8.80M 10-K · filed 2026-02-27 | |
| 2023-09-30 | -$1.00M 10-Q · filed 2024-11-07 | -$3.60M derived: sum of 2 quarters · filed 2024-11-07 | -$5.70M 10-Q · filed 2024-11-07 | $2.60M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-06-30 | -$2.60M 10-Q · filed 2024-11-07 | -$4.70M 10-Q · filed 2024-08-07 | $3.60M derived: sum of 3 quarters · filed 2025-03-04 | $4.50M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2023-03-31 | -$2.10M 10-Q · filed 2024-11-07 | $6.20M derived: sum of 2 quarters · filed 2025-03-04 | $7.10M derived: sum of 3 quarters · filed 2025-03-04 | $10.30M derived: sum of 4 quarters · filed 2025-03-04 | |
| 2022-12-31 | $8.30M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | $9.20M derived: sum of 2 quarters · filed 2025-03-04 | $12.40M derived: sum of 3 quarters · filed 2025-03-04 | $19.20M 10-K · filed 2025-03-04 | |
| 2022-09-30 | $900.00K 10-Q · filed 2023-12-11 | $4.10M derived: sum of 2 quarters · filed 2023-12-11 | $10.90M 10-Q · filed 2023-12-11 | $17.90M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-06-30 | $3.20M 10-Q · filed 2023-12-11 | $10.00M 10-Q · filed 2023-08-09 | $17.00M derived: sum of 3 quarters · filed 2024-03-08 | $16.30M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2022-03-31 | $6.80M 10-Q · filed 2023-12-11 | $13.80M derived: sum of 2 quarters · filed 2024-03-08 | $13.10M derived: sum of 3 quarters · filed 2024-03-08 | $15.10M derived: sum of 4 quarters · filed 2024-03-08 | |
| 2021-12-31 | $7.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-08 | $6.30M derived: sum of 2 quarters · filed 2024-03-08 | $8.30M derived: sum of 3 quarters · filed 2024-03-08 | $9.20M 10-K · filed 2024-03-08 | |
| 2021-09-30 | -$700.00K 10-Q · filed 2022-11-09 | $1.30M derived: sum of 2 quarters · filed 2022-11-09 | $2.20M 10-Q · filed 2022-11-09 | -$2.10M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2021-06-30 | $2.00M 10-Q · filed 2022-08-02 | $2.90M 10-Q · filed 2022-08-02 | -$1.40M derived: sum of 3 quarters · filed 2023-12-11 | -$600.00K derived: sum of 4 quarters · filed 2023-12-11 | |
| 2021-03-31 | $900.00K 10-Q · filed 2022-04-29 | -$3.40M derived: sum of 2 quarters · filed 2023-12-11 | -$2.60M derived: sum of 3 quarters · filed 2023-12-11 | -$3.60M derived: sum of 4 quarters · filed 2023-12-11 | |
| 2020-12-31 | -$4.30M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-12-11 | -$3.50M derived: sum of 2 quarters · filed 2023-12-11 | -$4.50M derived: sum of 3 quarters · filed 2023-12-11 | -$15.80M 10-K/A · filed 2023-12-11 | -$15.40M 10-K · filed 2021-02-19 |
| 2020-09-30 | $800.00K 10-Q · filed 2021-11-05 | -$200.00K derived: sum of 2 quarters · filed 2021-11-05 | -$11.50M 10-Q · filed 2021-11-05 | -$12.30M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | -$1.00M 10-Q · filed 2021-07-30 | -$12.30M 10-Q · filed 2021-07-30 | -$13.10M derived: sum of 3 quarters · filed 2022-02-25 | -$17.20M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | -$11.30M 10-Q · filed 2021-04-30 | -$12.10M derived: sum of 2 quarters · filed 2022-02-25 | -$16.20M derived: sum of 3 quarters · filed 2022-02-25 | -$16.70M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | -$4.90M derived: sum of 2 quarters · filed 2022-02-25 | -$5.40M derived: sum of 3 quarters · filed 2022-02-25 | -$4.40M 10-K · filed 2022-02-25 | |
| 2019-09-30 | -$4.10M 10-Q · filed 2020-11-06 | -$4.60M derived: sum of 2 quarters · filed 2020-11-06 | -$3.60M 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | -$500.00K 10-Q · filed 2020-07-31 | $500.00K 10-Q · filed 2020-07-31 | |||
| 2019-03-31 | $1.00M 10-Q · filed 2020-05-01 | ||||
| 2018-12-31 | -$1.80M 10-K · filed 2021-02-19 | ||||
| 2017-12-31 | $600.00K 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |